| 2-AG | 2-Arachidonoyl Glycerol |
| ACE-2 | Angiotensin-Converting Enzyme 2 |
| AD | Alzheimer’s Disease |
| AEA | Ethanolamide |
| ALS | Amyotrophic Lateral Sclerosis |
| ARDS | Acute Respiratory Distress Syndrome |
| ART | Anti-Retroviral Therapy |
| CBD | Cannabidiol |
| CB1 | Cannabinoid Receptor-1 |
| CB2 | Cannabinoid Receptor-2 |
| CBGA | Cannabigerolic Acid |
| CBR | Cannabinoid Receptors |
| CD | Crohn’s Disease |
| CNS | Central Nervous System |
| COPD | Chronic Obstructive Pulmonary Disease |
| CRS | Cytokine Release Syndrome |
| CUD | Cannabis Use Disorder |
| ECS | Endocannabinoid System |
| GABA | Gamma-Aminobutyric Acid |
| GALT | Gut-Associated Lymphoid Tissue |
| GI | Gastro Intestinal |
| GPCRs | G-Protein Coupled Receptors. |
| HIV | Human Immunodeficiency Virus |
| HAND | HIV-Associated Neurocognitive Disorders |
| HACVD | HIV-Associated Cardiovascular Disease |
| HAOMD | Oral Mucosal Disease/Dysfunction |
| IBD | Inflammatory Bowel Disease |
| LPI | Lysophosphotidylinositol |
| LPS | Lipopolysaccharide |
| MS | Multiple Sclerosis |
| MMP25 | Matrix Metalloproteinase 25 |
| PD | Parkinson’s Disease |
| PWH | People With HIV |
| RM | Rhesus Macaque |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Virus-2 |
| SIV | Simian Immunodeficiency Virus |
| THC | Δ9-Tetrahydrocannabinol |
| THCA | Tetrahydrocannabinolic acid |
| UC | Ulcerative Colitis |